Latest Videos |view all videos
Giuseppe Lanzino, M.D., and Alejandro A. Rabinstein, M.D., discuss treatment of patients with subarachnoid hemorrhages that result from ruptured brain aneurysms. This condition, one of the most complex acute conditions encountered in medicine, ...
Prashanthi Vemuri, Ph.D., presents Cognitive Decline in the Elderly and the Role of Cognitive Reserve.
Ronald Petersen, M.D., Ph.D., discusses a new scoring system to help determine which elderly people may be at a higher risk of developing the memory and thinking problems that can lead to dementia.
By examining more than 3,600 postmortem brains, researchers at Mayo Clinic have found that the progression of dysfunctional tau protein drives the cognitive decline and memory loss seen in Alzheimer's disease.
Researchers at Mayo Clinic's campus in Florida have developed a mouse model that exhibits the features associated with the most common genetic form of ALS and frontotemporal dementia.
Michelle M. Mielke, Ph.D., presents Identifying and Translating Biomarkers for Neurodegenerative Diseases: Experience With Sphingolipids.
Dean M. Wingerchuk, M.D., neurologist at Mayo Clinic's campus in Arizona, explains how the future holds promise for multiple sclerosis research.
A clinical trial co-led by Mayo Clinic Cancer Center researchers found that adding chemotherapy following radiation treatment improved survival for adults with low-grade gliomas by more than five years.
A diagnosis of chronic obstructive pulmonary disease (COPD) in older adults was associated with increased risk of mild cognitive impairment (MCI), especially MCI of skills other than memory.